Form 4: Incyte Director Harrigan Acquires Stock
Insider Transaction Report
Incyte Corporation Director Edmund Harrigan acquired 289 shares of common stock valued at $84.81 per share, increasing his beneficial ownership.
Summary
- Edmund Harrigan, a Director of Incyte Corp (INCY), acquired 289 shares of common stock on September 30, 2025.
- The shares were acquired at a price of $84.81 per share.
- This acquisition was made pursuant to a Rule 10b5-1 plan and represents restricted shares issued in lieu of quarterly director retainer fees.
- The restricted shares are fully vested upon issuance.
- Following this transaction, Mr. Harrigan beneficially owns an aggregate of 20,608 shares of Incyte common stock.
- This total includes 2,518 shares of common stock issuable pursuant to previously reported restricted stock units that have not yet vested.
Sentiment
Score: 7
Explanation: The sentiment is positive as a director is increasing their ownership stake in the company, signaling confidence and alignment with shareholder interests, even if it's part of routine compensation.
Positives
- A Director increasing their stake in the company, even as part of compensation, demonstrates alignment of interests with shareholders.
- The transaction was executed under a Rule 10b5-1 plan, indicating a pre-planned and transparent acquisition strategy.
Future Outlook
This filing does not contain forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This insider transaction is specific to Incyte Corporation and its director compensation structure, and does not directly reflect broader industry trends or competitive dynamics.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation | Restricted shares were issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees, pursuant to an election intended to comply with Rule 10b5-1. | 09/30/2025 | This reflects the company's ongoing practice of compensating directors with equity, aligning their interests with long-term shareholder value. |
Stakeholder Impact
- Shareholders may view the director's increased ownership as a positive signal of confidence in the company's future prospects and management's commitment.
Key Dates
| Date | Description |
|---|---|
| 09/30/2025 | Date of transaction where Edmund Harrigan acquired 289 shares of Incyte common stock. |
| 10/02/2025 | Date the Form 4 was signed by Elizabeth Feeney, Attorney-In-Fact for Edmund Harrigan. |
Recommendation
holdThe acquisition of shares by a director, even as part of compensation, generally signals confidence in the company's future. While not a large open-market purchase, it reinforces alignment between management and shareholders. This transaction supports a 'hold' recommendation for existing investors, indicating no immediate reason to sell, and could be a minor positive factor for those considering an investment.
Keywords
Incyte Corp, INCY, Form 4, Insider Transaction, Director Stock Acquisition, Rule 10b5-1, Restricted Stock, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.